Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$13.35−0.37 (-2.70%)
Close on Nov 12, 2026Market cap $2.01BP/E –Yield 3.84%
Chemours r&d expenses
Research and development expenses are spending on new products and technology.
Chemours's R&D Expenses for the twelve months ending Sep 30, 2026 was $104.00M, down 2.8% year over year. For fiscal 2025 it was $108.00M, down 0.9% from the year before. Over ten years it grew 1.1% a year on average. The highest annual figure on record is $164.00M in fiscal 2013.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $108.00M | -0.9% |
| FY2024 | Dec 31, 2024 | $109.00M | +0.9% |
| FY2023 | Dec 31, 2023 | $108.00M | -8.5% |
| FY2022 | Dec 31, 2022 | $118.00M | +10.3% |
| FY2021 | Dec 31, 2021 | $107.00M | +15.1% |
| FY2020 | Dec 31, 2020 | $93.00M | +16.3% |
| FY2019 | Dec 31, 2019 | $80.00M | -2.4% |
| FY2018 | Dec 31, 2018 | $82.00M | +1.2% |
| FY2017 | Dec 31, 2017 | $81.00M | 0.0% |
| FY2016 | Dec 31, 2016 | $81.00M | -16.5% |
| FY2015 | Dec 31, 2015 | $97.00M | -32.2% |
| FY2014 | Dec 31, 2014 | $143.00M | -12.8% |
| FY2013 | Dec 31, 2013 | $164.00M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $24.00M | -7.7% |
| Q2 FY2026 | Jun 30, 2026 | $27.00M | -3.6% |
| Q1 FY2026 | Mar 31, 2026 | $26.00M | -3.7% |
| Q4 FY2025 | Dec 31, 2025 | $27.00M | +3.8% |
| Q3 FY2025 | Sep 30, 2025 | $26.00M | -10.3% |
| Q2 FY2025 | Jun 30, 2025 | $28.00M | +7.7% |
| Q1 FY2025 | Mar 31, 2025 | $27.00M | -3.6% |
| Q4 FY2024 | Dec 31, 2024 | $26.00M | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | $29.00M | +3.6% |
| Q2 FY2024 | Jun 30, 2024 | $26.00M | -7.1% |
| Q1 FY2024 | Mar 31, 2024 | $28.00M | +7.7% |
| Q4 FY2023 | Dec 31, 2023 | $26.00M | -13.3% |
| Q3 FY2023 | Sep 30, 2023 | $28.00M | -12.5% |
| Q2 FY2023 | Jun 30, 2023 | $28.00M | +12.0% |
| Q1 FY2023 | Mar 31, 2023 | $26.00M | -13.3% |
| Q4 FY2022 | Dec 31, 2022 | $30.00M | +3.4% |
| Q3 FY2022 | Sep 30, 2022 | $32.00M | +18.5% |
| Q2 FY2022 | Jun 30, 2022 | $25.00M | -7.4% |
| Q1 FY2022 | Mar 31, 2022 | $30.00M | +25.0% |
| Q4 FY2021 | Dec 31, 2021 | $29.00M | +11.5% |
| Q3 FY2021 | Sep 30, 2021 | $27.00M | +22.7% |
| Q2 FY2021 | Jun 30, 2021 | $27.00M | +35.0% |
| Q1 FY2021 | Mar 31, 2021 | $24.00M | 0.0% |
| Q4 FY2020 | Dec 31, 2020 | $26.00M | +36.8% |
| Q3 FY2020 | Sep 30, 2020 | $22.00M | +10.0% |
| Q2 FY2020 | Jun 30, 2020 | $20.00M | +5.3% |
| Q1 FY2020 | Mar 31, 2020 | $24.00M | +9.1% |
| Q4 FY2019 | Dec 31, 2019 | $19.00M | -9.5% |
| Q3 FY2019 | Sep 30, 2019 | $20.00M | 0.0% |
| Q2 FY2019 | Jun 30, 2019 | $19.00M | -5.0% |
| Q1 FY2019 | Mar 31, 2019 | $22.00M | +10.0% |
| Q4 FY2018 | Dec 31, 2018 | $21.00M | +10.5% |
| Q3 FY2018 | Sep 30, 2018 | $20.00M | 0.0% |
| Q2 FY2018 | Jun 30, 2018 | $20.00M | -4.8% |
| Q1 FY2018 | Mar 31, 2018 | $20.00M | +5.3% |
| Q4 FY2017 | Dec 31, 2017 | $19.00M | -9.5% |
| Q3 FY2017 | Sep 30, 2017 | $20.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $21.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $19.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.00M | – |
See a number that looks wrong?